Advanced Search

 

Study ID Status Title Patient Level Data
LPT108741 Terminated A Phase II, Placebo Controlled, Double-Blind, Randomized, Discontinuation Study of Lapatinib Administered Orally to Subjects with ErbB2 Positive Ovarian, Gastric/Esophageal Adenocarcinoma, Uterine Serous Papillary, or Bladder Cancer
LPT109096 Completed Phase II Randomized Trial of Neoadjuvant Trastuzumab and/or Lapatinib plus Chemotherapy (Sequential FEC75 and Paclitaxel) in Women with ErbB2- (HER2/neu-) Overexpressing Invasive Breast Cancer
LPT109747 Completed An exploratory, phase II trial to determine the association of lapatinib induced fluoropyrimidine gene changes with efficacy parameters of lapatinib and capecitabine in first line gastric cancer
LPT111110 Terminated A Phase II, Single-Arm, Multi-Center Study Evaluating the Combination of Vinorelbine and Lapatinib in Women with ErbB2 Overexpressing Metastatic Breast Cancer
LPT111111 Active not recruiting LPT 111111- A Single-arm, Multicenter Phase II Study to Evaluate The Combination of Weekly Nanoparticle Albumin bound Paclitaxel (nab-Paclitaxel or ABRAXANE®) and Lapatinib (TYKERB®) in Women With No More Than One Prior Treatment for ErbB2 Overexpressing Metastatic Breast Cancer
LTG9603 Completed Use of Lamotrigine Adjunctive Therapy in Patients With Mental Retardation and Epilepsy: A Multicentre, Double-Blind, Placebo-Controlled Study with Evaluation of Behavioural Effects.
M00026/012 Completed An open, randomised, multicentre, phase II study to evaluate the safety and therapeutic efficacy of an investigational vaccination regimen versus Lamivudine in adult patients with HBeAg positive chronic Hepatitis B.Lamivudine (Lam): GlaxoSmithKline (GSK) Biologicals’ cytosine nucleoside analogue…
M00026/016 Completed An open, randomised, multicentre, phase I/II study to evaluate the safety and therapeutic efficacy of an investigational vaccination regimen versus Lamivudine, in adult patients with HBeAg negative, anti-HBe antibody positive chronic…
M00026-012 Completed An open, randomised, multicentre, phase II study to evaluate the safety and therapeutic efficacy of an investigational vaccination regimen versus Lamivudine in adult patients with HBeAg positive chronic Hepatitis B.
MAB104954 Completed A study to optimise the propranolol block model for assessment of the pharmacological activity of bronchodilators in healthy volunteers. Study Listed on ClinicalStudyDataRequest.com
MAB104958 Completed See Detailed Description Study Listed on ClinicalStudyDataRequest.com
MAB108115 Completed A randomised, double-blind, dose escalating study in healthy volunteers to assess the safety, tolerability, extra pulmonary pharmacodynamics and pharmacokinetics of single doses of GSK961081 (succinate salt) Study Listed on ClinicalStudyDataRequest.com
MAB110123 Completed A randomized, double-blind, crossover study to investigate the bronchodilatation post-inhalation of GSK961081 alone and with the addition of cumulative doses of short acting bronchodilators (salbutamol and ipratropium bromide) in patients with COPD Study Listed on ClinicalStudyDataRequest.com
MAB110553 Completed A study to investigate the relative pharmacological activity of aninhaled B2-agonist/anticholinergic dual pharmacophore inhealthy volunteers Study Listed on ClinicalStudyDataRequest.com
MAD105516 Completed A randomized, double-blind, placebo-controlled, crossover study to evaluate the effects of morning administration of GW679769 (10mg and 30 mg) on polysomnograph sleep recordings, subjective sleep assessment, daytime cognition and psychomotor function in subjects with primary insomnia
MAG103114 Completed A single-blind, single dose, placebo controlled, parallel group, first time in human study to assess the safety, tolerability, pharmacokinetics and immunogenicity of ascending IV doses of GSK249320 in healthy volunteers Study Listed on ClinicalStudyDataRequest.com
MAL10907 Completed An open label, parallel group, single oral dose study to investigate the pharmacokinetics of MALARONE in healthy elderly subjects compared to healthy young subjects
MAL10908 Completed An open label, parallel group, single oral dose study to investigate the pharmacokinetics of MALARONE in subjects with severe renal impairment compared to healthy subjects.
MAL10909 Completed An Open Label, Parallel Group, Single Oral Dose Study to Investigate the Pharmacokinetics of MALARONE in Subjects with Mild to Moderate Hepatic Impairment Compared to Healthy Subjects
MAL30010 Completed An International, Randomized, Double-Blind Study to Compare the Safety and Efficacy of MALARONE (Atovaquone and Proguanil Hydrochloride) Versus Mefloquine for Chemoprophylaxis Against Malaria in Non-Immune Travelers
MAL30011 Completed An International, Randomized, Double-Blind Study to Compare the Safety and Efficacy of MALARONE (Atovaquone and Proguanil Hydrochloride) Versus Chloroquine and Proguanil Hydrochloride for Chemoprophylaxis Against Malaria in Non-Immune Travelers
MAL30012 Completed An International, Randomized, Open-Label Study to Compare the Safety and Efficacy of MALARONE (Atovaquone and Proguanil Hydrochloride) Versus Chloroquine and Proguanil Hydrochloride for Chemoprophylaxis Against Malaria in Non-Immune Pediatric Travelers
MAL30013 Completed An Open-Label Comparative Study to Determine the Safety and Efficacy of MALARONE (Atovaquone and Proguanil Hydrochloride) Versus Amodiaquine in the Treatment of Acute Plasmodium falciparum Malaria in Children Weighing 5 and <11kg in Gabon
MAL30014 Completed A Randomized, Double-Blind, Placebo-Controlled Study of MALARONE (Atovaquone and Proguanil Hydrochloride) as a Causal Prophylactic Agent Against Mosquito-Transmitted P. falciparum Malaria in Healthy Non-Immune Volunteers
MAL30015 Completed A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MALARONE (Atovaquone and Proguanil Hydrochloride) for the Prevention of Plasmodium falciparum Malaria in Gabonese Children, and the Effect on Antibody Response to Typhoid and Cholera Vacci ...

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.